« Previous
Next »
Titles
- An assessment of beneficiary knowledge of Medicare coverage options and the prescription drug benefit1
- Beyond age rating: spreading risk in health insurance markets1
- Concerns about opioid use in Medicare Part D in the Appalachian region1
- Doors to extra help: boosting enrollment in the Medicare Part D low-income subsidy1
- Electronic prescribing of controlled substances among office-based physicians: 20171
- How do prescription drugs affect the use of other health services?1
- Medicare Advantage 2017 spotlight: enrollment market update1
- Medicare at 50: origins and evolution1
- Opioid overdoses and the limited treatment of opioid use disorder continue to be concerns for Medicare beneficiaries1
- Opioid use decreased in Medicare Part D, while medication-assisted treatment increased1
- Opioid use in Medicare Part D during the onset of the COVID-19 pandemic1
- Opioid use in Medicare Part D in Missouri1
- Opioid use in Medicare Part D remains concerning1
- Part D plans generally include drugs commonly used by dual eligibles: 20181
- Part D plans generally include drugs commonly used by dual eligibles: 20221
- Part D plans generally include drugs commonly used by dual-eligible enrollees: 20231
- Prescription drugs and Medicare Part D: a report on access, satisfaction, and cost1
- Prescription opioids: Medicare needs to expand oversight efforts to reduce the risk of harm : report to Congressional requesters1
- Some Medicare Part D beneficiaries face avoidable extra steps that can delay or prevent access to prescribed drugs1
- The Medi-Cal prescription drug benefit: an overview1